Dr. Reichel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
99 Business Park Drive
Armonk, NY 10504Phone+1 914-849-7600Fax+1 914-849-7696
Summary
- Dr. Ronald Reichel is a nephrologist in White Plains, NY and is affiliated with White Plains hospital. He received his medical degree from Chicago Medical School at Rosalind Franklin University (N. Chicago, IL) and has been in practice 19 years. He completed a Medical residency at Montefiore Medical Center (Bronx, NY) and a Nephrology fellowship at UC San Francisco. He also speaks multiple languages, including German. He specializes in acute renal failure and is experienced in numerous dialysis modalities.
Education & Training
- University of California (San Francisco)Fellowship, Nephrology, 2004 - 2006
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2001 - 2004
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2001
Certifications & Licensure
- CA State Medical License 2004 - 2026
- NY State Medical License 2003 - 2026
- CT State Medical License 2024 - 2025
- LA State Medical License 2009 - 2021
- MS State Medical License 2020 - 2021
- WA State Medical License 2010 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 2 citationsHydralazine-Induced Isolated Lupus Nephritis.Naseer Khan, Ronald R. Reichel, Ayesha Khurshid, Katie Tso, Joan Broussard
Ochsner Journal. 2020-01-01 - 7 citationsAcute kidney injury: quoi de neuf?Ronald R. Reichel
Ochsner Journal. 2014-09-21 - 21 citationsThe HNF-3alpha transcription factor is a primary target for retinoic acid action.Alexander Jacob, Shalini Budhiraja, Ronald R. Reichel
Experimental Cell Research. 1999-07-10
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: